Fluoropharma Medical
FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. The company was founded in 2003 and is headquartered in Montclair, New Jersey.
Market Cap & Net Worth: Fluoropharma Medical (FPMI)
Fluoropharma Medical (PINK:FPMI) has a market capitalization of $3.43K ($3.43K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #46719 globally and #14525 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Fluoropharma Medical's stock price $0.00 by its total outstanding shares 34262264 (34.26 Million).
Fluoropharma Medical Market Cap History: 2015 to 2025
Fluoropharma Medical's market capitalization history from 2015 to 2025. Data shows change from $10.28 Million to $3.43K (-57.26% CAGR).
Fluoropharma Medical Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Fluoropharma Medical's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of FPMI by Market Capitalization
Companies near Fluoropharma Medical in the global market cap rankings as of March 19, 2026.
Key companies related to Fluoropharma Medical by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Fluoropharma Medical Historical Marketcap From 2015 to 2025
Between 2015 and today, Fluoropharma Medical's market cap moved from $10.28 Million to $ 3.43K, with a yearly change of -57.26%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $3.43K | 0.00% |
| 2024 | $3.43K | 0.00% |
| 2023 | $3.43K | -93.33% |
| 2022 | $51.39K | +1400.00% |
| 2021 | $3.43K | -94.12% |
| 2020 | $58.25K | -19.05% |
| 2019 | $71.95K | -97.00% |
| 2018 | $2.40 Million | -12.50% |
| 2017 | $2.74 Million | -28.25% |
| 2016 | $3.82 Million | -62.83% |
| 2015 | $10.28 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Fluoropharma Medical was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.43K USD |
| MoneyControl | $3.43K USD |
| MarketWatch | $3.43K USD |
| marketcap.company | $3.43K USD |
| Reuters | $3.43K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.